Compare AbCellera Biologics Inc (ABCL) vs Booz Allen Hamilton Holding Corporation (BAH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Booz Allen Hamilton Holding Corporation — how do they compare? AbCellera Biologics Inc trades at $9.12 (market cap $2.99B), while Booz Allen Hamilton Holding Corporation trades at $78.21 (market cap $9.45B). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 3.2× AbCellera Biologics Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | BAH | |
|---|---|---|
Market Cap | $2.99B | $9.45B |
Sector | Health | Industrials |
52-Week High | $9.76 | $111.63 |
52-Week Low | $2.78 | $59.71 |
Enterprise Value | $2.58B | $13.07B |
Dividend Yield | — | 3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
Read more on BAH →
